drugset / Trial / NCT06439953

Irrisept Solution for Instrumented Spine Surgery

NCT06439953

Recruiting 200 enrolled Rhode Island Hospital
RandomizedParallel-groupSingle-blindPrevention

Summary

Various spine surgeons perform wound irrigation using saline mixed with vancomycin, relying on mechanical debridement of non-viable tissue, physical disruption of biofilm, and bacteriostatic effect against gram positive flora. When used as a powder, topical application of vancomycin has demonstrated increased risk of symptomatic seroma formation, which is an adverse outcome that often requires bedside or intra-operative aspiration. Broad-spectrum antiseptic agents, such as Irrisept, offer bacteriocidal properties to eliminate hardware inoculation, thereby minimizing the risk of deep space infection, while obviating the risk of seroma development.

Timeline

Start
2024-10-01
Primary completion
2026-09-30
Completion
2026-09-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorhexidine gluconate solution Unknown 0.05 % Other
Comparator Vancomycin Other / unclassified Other

Indications